Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

November 30, 2001

Study Completion Date

September 30, 2004

Conditions
SchizophreniaSchizoaffective DisorderPsychotic Disorders
Interventions
DRUG

ziprasidone versus olanzapine , risperidone or quetiapine

BEHAVIORAL

Panss , CGI-C, UKU-SERS-Pa

PROCEDURE

Blood tests

Trial Locations (43)

101

Pfizer Investigational Site, Reykjavik

1003

Pfizer Investigational Site, Lausanne

1197

Pfizer Investigational Site, Prangins

1225

Pfizer Investigational Site, Chêne-Bourg

2100

Pfizer Investigational Site, Copenhagen

2300

Pfizer Investigational Site, København S

2600

Pfizer Investigational Site, Glostrup Municipality

2750

Pfizer Investigational Site, Ballerup Municipality

4125

Pfizer Investigational Site, Riehen

4293

Pfizer Investigational Site, Dianalund

4300

Pfizer Investigational Site, Holbæk

4760

Pfizer Investigational Site, Vordingborg

4915

Pfizer Investigational Site, Saint Urban

5000

Pfizer Investigational Site, Odense C

6000

Pfizer Investigational Site, Kolding

6100

Pfizer Investigational Site, Haderslev

6440

Pfizer Investigational Site, Augustenborg

6700

Pfizer Investigational Site, Esbjerg

6715

Pfizer Investigational Site, Esbjerg N

6950

Pfizer Investigational Site, Ringkøbing

7100

Pfizer Investigational Site, Vejle

7620

Pfizer Investigational Site, Lemvig

8000

Pfizer Investigational Site, Arhus C

8029

Pfizer Investigational Site, Zurich

8240

Pfizer Investigational Site, Risskov

8620

Pfizer Investigational Site, Kjellerup

8800

Pfizer Investigational Site, Viborg

9000

Pfizer Investigational Site, Sankt Gallen

9100

Pfizer Investigational Site, Aalborg

9460

Pfizer Investigational Site, Brovst

20700

Pfizer Investigational Site, Turku

30101

Pfizer Investigational Site, Forssa

50520

Pfizer Investigational Site, Mikkeli

95410

Pfizer Investigational Site, Kiviranta

00099

Pfizer Investigational Site, Helsinki

04400

Pfizer Investigational Site, Järvenpää

04301

Pfizer Investigational Site, Tuusula

CH-4025

Pfizer Investigational Site, Basel

CH-3000

Pfizer Investigational Site, Bern

CH - 1630

Pfizer Investigational Site, Bulle

CH-2800

Pfizer Investigational Site, Delémont

CH-8618

Pfizer Investigational Site, Oetwil

CH-4503

Pfizer Investigational Site, Solothurn

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00159770 - Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients | Biotech Hunter | Biotech Hunter